Investview

INVU · OTC

$0.0165+$0.00 (+0.00%)TodayMarket closed ·
Prev close $0.0165

Latest news

  • Press releaseGlobe Newswire

    Investview, Inc. Reports Second-Quarter 2026 Financial Results and Strategic Business Update

  • Press releaseGlobe Newswire

    ConectivGlobal Unveils Expanded Platform with Launch of ConeqtX and MyLife Wellness

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Reports Financial Results and Operational Highlights for the First Quarter Ended March 31, 2026

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Reports Full Year 2025 Financial Results, Operational Highlights, and a Year-End Message from the CEO

  • Press releaseGlobe Newswire

    Investview Announces Official Launch of myLife Wellness, Establishing a New Consumer Health & Wellness Business Unit

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Reports Financial Results, Current Operational and Financial Highlights for the Second Quarter Ended June 30, 2025

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Reports Financial Results and Current Operational and Financial Highlights for the First Quarter Ended March 31, 2025

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Reports Full Year 2024 Financial Results, Operational Highlights and a Year-End Message from the CEO

  • Press releaseGlobe Newswire

    INVESTVIEW, INC. ANNOUNCES LAUNCH OF STOCK REPURCHASE PROGRAM

  • Press releaseGlobe Newswire

    Investview, Inc. ("INVU") Announces the Acquisition of Renu Laboratories Inc., a manufacturer of proprietary and other health, beauty and wellness products.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.